Article
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.
Nature genetics - 1 Feb 2011
Zhou Kaixin, Bellenguez Celine, Spencer Chris C A, Bennett Amanda J, Coleman Ruth L, Tavendale Roger, Hawley Simon A, Donnelly Louise A, Schofield Chris, Groves Christopher J, Burch Lindsay, Carr Fiona, Strange Amy, Freeman Colin, Blackwell Jenefer M, Bramon Elvira, Brown Matthew A, Casas Juan P, Corvin Aiden, Craddock Nicholas, Deloukas Panos, Dronov Serge, Duncanson Audrey, Edkins Sarah, Gray Emma, Hunt Sarah, Jankowski Janusz, Langford Cordelia, Markus Hugh S, Mathew Christopher G, Plomin Robert, Rautanen Anna, Sawcer Stephen J, Samani Nilesh J, Trembath Richard, Viswanathan Ananth C, Wood Nicholas W, Harries Lorna W, Hattersley Andrew T, Doney Alex S F, Colhoun Helen, Morris Andrew D, Sutherland Calum, Hardie D Grahame, Peltonen Leena, McCarthy Mark I, Holman Rury R, Palmer Colin N A, Donnelly Peter, Pearson Ewan R
Abstract excerpt
Metformin is the most commonly used pharmacological therapy for type 2 diabetes. We report a genome-wide association study for glycemic response to metformin in 1,024 Scottish individuals with type 2 diabetes with replication in two cohorts including 1,783 Scottish individuals and 1,113 individuals from the UK Prospective Diabetes Study. In a combined meta-analysis, we identified a SNP, rs11212617, associated...
Read the complete abstract on PubMed